Nutrition
Latest news and updates related to nutrition
About Nutrition coverage
The Nutrition news hub on Global Investing News tracks 4 recent headlines that matter to investors, policy watchers, and market strategists. Use this page to monitor how Nutrition developments affect earnings expectations, sector rotation, supply chains, regulation, and cross-asset volatility. Stories are grouped by source type — market data, company announcements, regulatory filings, and expert analysis — so you can scan the signal quickly without wading through duplicate wire copy. When a headline links to a full article, you will find expanded context, key facts, and prediction-market angles where available. Bookmark this hub if you follow Nutrition across quarters; new items are added as our crawl pipeline ingests fresh sources throughout the trading day.
Explore related topics
Latest Nutrition headlines
Market Data
(2)Abbott Stock Is on Pace for Worst Day Since 2000. The Nutrition Business Is a Drag on Earnings.
Abbott Laboratories (ABT) is facing significant selling pressure as its nutrition segment once again becomes a focal point of investor concern. While the company's Medical Devices division—bolstered by strong FreeStyle Libre sales—continues to perform well, the nutrition business is struggling with persistent headwinds linked to market share recovery and ongoing litigation risks surrounding its preterm infant formula. This disconnect between the high-growth med-tech portfolio and the stagnant nutrition wing has led to a valuation recalibration. Historically, Abbott has been a defensive staple, but the scale of today's decline suggests that institutional investors are repricing the legal liabilities associated with the necrotizing enterocolitis (NEC) lawsuits, which have recently seen unfavorable jury awards against competitors and Abbott alike. Investors should monitor upcoming court rulings and the company's ability to maintain its full-year guidance in the face of these legal expenses and shifting consumer dynamics in the pediatric nutrition space. The long-term investment case now hinges on whether the robust 10%+ growth in medical devices can sufficiently offset the volatility in the lower-margin nutrition business.
Abbott Stock Slumps. The Nutrition Business Is a Drag on Earnings.
Abbott Laboratories (ABT) is facing significant headwinds as its pediatric nutrition segment continues to weigh on overall financial performance, overshadowing gains in its medical device and diagnostics divisions. This slump is primarily rooted in the lingering aftermath of the 2022 infant formula recall and the subsequent closure of its Sturgis facility, which has allowed competitors like Reckitt Benckiser to gain market share. While Abbott has restored much of its production capacity, the recovery of consumer trust and shelf space remains a slow, capital-intensive process. From a broader sector perspective, this highlights a divergence within the healthcare conglomerate: while the medical device segment thrives—driven by the FreeStyle Libre glucose monitor and recovery in elective surgeries—the nutrition business remains a multi-year recovery story. Investors should view this as a transitionary phase where the high-margin med-tech business is being offset by lower-margin specialty retail recovery. Forward-looking, the key metric for investors will be whether the anticipated double-digit growth in medical devices can accelerate enough to compensate for the stagnation in the nutrition segment, especially as birth rates trend lower in key markets.
Other Sources
(2)FDA Commissioner on New Nutrition Guidelines, Flu Surge
The FDA Commissioner discussed the agency's new nutrition guidelines aimed at improving public health and combating diet-related diseases. Additionally, the commissioner addressed the ongoing flu surge, likely providing updates on vaccine efficacy and public health measures to mitigate its impact. This indicates an intersection of long-term health policy and immediate public health concerns.
RFK Jr. announces new nutrition guidelines, pushing more protein and less processed food
Robert F. Kennedy Jr., a presidential candidate, has unveiled new nutrition guidelines for Americans, advocating for a diet higher in protein and significantly reducing processed food consumption. This initiative aligns with growing public interest in health and wellness and could influence dietary trends if his platform gains traction.
Get alerts for this topic
Subscribe to receive updates about "Nutrition"